0001104659-23-090452.txt : 20230811 0001104659-23-090452.hdr.sgml : 20230811 20230811160057 ACCESSION NUMBER: 0001104659-23-090452 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230810 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Glass Geoffrey Michael CENTRAL INDEX KEY: 0001517718 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37977 FILM NUMBER: 231163865 MAIL ADDRESS: STREET 1: 4721 EMPEROR BLVD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001012477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK STREET 2: BALLYCOOLIN CITY: DUBLIN STATE: L2 ZIP: 15 BUSINESS PHONE: 636-449-1830 MAIL ADDRESS: STREET 1: 16640 CHESTERFIELD GROVE ROAD STREET 2: SUITE 200 CITY: CHESTERFIELD STATE: MO ZIP: 63005 FORMER COMPANY: FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA DATE OF NAME CHANGE: 19960422 4 1 tm2323514-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-08-10 0 0001012477 AVADEL PHARMACEUTICALS PLC AVDL 0001517718 Glass Geoffrey Michael C/O AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 IRELAND 1 0 0 0 0 ADSs 2023-08-10 4 P 0 14000 13.40 A 59000 I By Trust ADSs 65700 I By Trust The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts. These ADSs are held by The Geoffrey Glass Trust of which the reporting person is a co-trustee. The reporting person is the sole beneficiary of the trust. These ADSs are held by Geoffrey M. Glass Revocable Trust U/T/D August 26, 2020 of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust. /s/ Jerad G. Seurer, Attorney-in-Fact 2023-08-11